BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30928422)

  • 1. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study.
    Di Giorgio A; De Angelis P; Cheli M; Vajro P; Iorio R; Cananzi M; Riva S; Maggiore G; Indolfi G; Calvo PL; Nicastro E; D'Antiga L
    Dig Liver Dis; 2019 Aug; 51(8):1179-1184. PubMed ID: 30928422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt.
    Orloff MJ; Orloff MS; Girard B; Orloff SL
    J Am Coll Surg; 2002 Jun; 194(6):717-28; discussion 728-30. PubMed ID: 12081062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z; Zhao H; Wang X; Zhang H; Jiang M; Tsauo J; Luo X; Yang L; Li X
    Abdom Imaging; 2015 Aug; 40(6):1813-20. PubMed ID: 25504374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.
    Gairing SJ; Kloeckner R; Pitton MB; Baumgart J; von Auer-Wegener C; Lang H; Galle PR; Foerster F; Schattenberg JM
    Z Gastroenterol; 2021 Jan; 59(1):43-49. PubMed ID: 33429449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening variceal bleeding after liver transplantation and extensive portal vein thrombosis: Desperate times call for desperate measures.
    de Assis A; de Carvalho Melo JA; Kawakami WY; Moreira AM; Carnevale FC; Massami H; Hirschfeld APM; Pugliese RPS; Foronda FK; Paulino RG; de Araújo AA; Fonseca EA; Seda Neto J
    Pediatr Transplant; 2023 Dec; 27(8):e14555. PubMed ID: 37291909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
    Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and prognostic factors in non-cirrhotic non-neoplastic patients with portal vein thrombosis: A single-centre experience.
    Gioia S; Riggio O; Nardelli S; Ridola L; Marzano C
    Dig Liver Dis; 2023 Nov; 55(11):1487-1495. PubMed ID: 37230857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenterico left portal bypass for variceal bleeding owing to extrahepatic portal hypertension caused by portal vein thrombosis.
    Ateş O; Hakgüder G; Olguner M; Seçil M; Karaca I; Akgür FM
    J Pediatr Surg; 2006 Jul; 41(7):1259-63. PubMed ID: 16818059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cirrhotic portal hypertension - diagnosis and management.
    Khanna R; Sarin SK
    J Hepatol; 2014 Feb; 60(2):421-41. PubMed ID: 23978714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.
    Lv Y; He C; Guo W; Yin Z; Wang J; Zhang B; Meng X; Cai J; Luo B; Wu F; Niu J; Fan D; Han G
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):233-41. PubMed ID: 26381818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra hepatic portal vein obstruction leading to variceal bleed due to portal hypertension.
    Rehman SU; Amin MF
    J Pak Med Assoc; 2005 Jan; 55(1):42-4. PubMed ID: 15816697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.
    Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K
    Z Gastroenterol; 2018 Mar; 56(3):221-237. PubMed ID: 29113006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children.
    Lautz TB; Keys LA; Melvin JC; Ito J; Superina RA
    J Am Coll Surg; 2013 Jan; 216(1):83-9. PubMed ID: 23177370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.